Saturna Capital Corp Elanco Animal Health Inc Transaction History

Saturna Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	BUY	$18.94 - $24.93 $75,760 - $99,720	4,000 Added 26.3%	19,209 $412,000
Q4 2019 Feb 13, 2020	SELL	$25.29 - $29.45 $23,266 - $27,094	-920 Reduced 5.7%	15,209 $448,000
Q2 2019 Jul 31, 2019	BUY	$31.11 - $34.79 $102,663 - $114,807	3,300 Added 25.72%	16,129 $545,000
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $372,041 - $421,176	12,829 New	12,829 $411,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Saturna Capital Corp with notifications on news.